Resources

Type of publications
Regions
Diseases

5192 results found

2024 ∙ Tinessia, A. Clark, K. Randell, M. Leask, J. King, C.

Strategies to address COVID-19 vaccine hesitancy in First Nations peoples: a systematic review

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Du, P. Jin, S. Lu, S. Wang, L. Ma, X. Wang, J. Huang, R. Luo, Q. Yang, S. Feng, X.

Strategies to increase the coverage of influenza and pneumonia vaccination in older adults: a systematic review and network meta-analysis

  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ de Koning, R. Gonzalez Utrilla, M. Spanaus, E. Moore, M. Lomazzi, M.

Strategies used to improve vaccine uptake among healthcare providers: A systematic review

  • Healthcare workers
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Diakite, I. Martins, B. Owusu-Edusei, K. Palmer, C. Patterson-Lomba, O. Gomez-Lievano, A. Zion, A. Simpson, R. Daniels, V. Elbasha, E.

Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts

  • All age groups
  • Human papillomavirus (HPV)
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Riemma, G. Etrusco, A. Laganà, A. S. Torella, M. Vastarella, M. G. Della Corte, L. D'Amato, A. La Verde, M. De Franciscis, P. Cobellis, L.

Susceptibility to Infection and Impact of COVID-19 Vaccines on Symptoms of Women with Endometriosis: A Systematic Review and Meta-Analysis of Available Evidence

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Wong, B. K. Mabbott, N. A.

Systematic review and meta-analysis of COVID-19 mRNA vaccine effectiveness against hospitalizations in adults

  • Adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Marra, F. Yip, M. Cragg, J. J. Vadlamudi, N. K.

Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations

  • Adults
  • Older adults
  • Herpes zoster
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Levin, A. Yeung, K. H. T. Hutubessy, R.

Systematic review of cost projections of new vaccine introduction

  • All age groups
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Moradiya, P. Khandelwal, P. Raina, R. Mahajan, R. G.

Systematic Review of Individual Patient Data COVID-19 Infection and Vaccination-Associated Thrombotic Microangiopathy

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Williams, S. V. Akande, T. Abbas, K.

Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria

  • Africa
  • Nigeria
  • Newborn
  • Children
  • Low and Middle Income Countries
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...